We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,675 results
  1. Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue

    Parkinson’s disease (PD) is a progressive neurodegenerative disease of the brain due to degeneration of dopaminergic neurons in the substantia nigra...

    Areej Turkistani, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Molecular Neurobiology
    Article Open access 17 February 2024
  2. Graded Differentiation of Glioma in GSK-3 β: The Study and Analysis of the Expression Difference and Its Significance in the Endoplasmic Reticulum Stress Apoptosis Pathway

    Abstract

    Glioma accounts for 80% of malignant central nervous system, with high incidence and extremely difficult to cure. However, for the role of ER...

    Hong Song, Guoliang Mao, ... Rui Pang in Neurochemical Journal
    Article 27 May 2024
  3. Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer’s Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation

    Insulin signaling disruption and caspase-3 cleavage play a pathologic role in Alzheimer’s disease (AD). Evidence suggested that cinnamaldehyde (Cin),...

    Saeid Bagheri-Mohammadi, Sahar Askari, ... Rasoul Ghasemi in Journal of Molecular Neuroscience
    Article 10 October 2022
  4. Proposed hypothesis of GSK-3 β inhibition for stimulating Wnt/β-catenin signaling pathway which triggers liver regeneration process

    Almost every human organ has a poor ability to regenerate, notable exceptions are liver, skin, gut, etc. Molecular and cellular underpinnings of...

    Chirag Khurana, Onkar Bedi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 25 January 2022
  5. α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks

    In Parkinson’s disease, the dysfunction of the dopaminergic nigrostriatal tract involves the loss of function of dopaminergic neurons of the...

    Ángel Juan García-Yagüe, Isabel Lastres-Becker, ... Antonio Cuadrado in Molecular Neurobiology
    Article Open access 05 October 2021
  6. Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats

    Rationale

    Δ 9 -tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis and is responsible for cannabis-related neuropsychiatric...

    Roger Hudson, Christopher Norris, ... Steven R. Laviolette in Psychopharmacology
    Article 03 December 2021
  7. Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells

    Objective

    The threonine/serine kinase glycogen synthase kinase 3 (GSK-3) targets multiple substrates in T-cells, regulating the expression of Tbet and...

    Alison Taylor, Christopher E. Rudd in BMC Research Notes
    Article Open access 18 March 2020
  8. Exploring the Diverse Roles of GSK-3β Kinase in Alzheimer’s Disease

    Alzheimer’s disease, a progressive neurodegenerative disorder, is a global health concern whose consequence affects an individual’s cognitive scores,...
    Gadde Shareena, Dileep Kumar, Nanasaheb Thorat in Deciphering Drug Targets for Alzheimer’s Disease
    Chapter 2023
  9. Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease

    Alzheimer’s Disease (AD) is the most prevalent form of age-related dementia. Even though a century has passed since the discovery of AD, the exact...

    Ronnita C. Sequeira, Angel Godad in Molecular Neurobiology
    Article 08 December 2023
  10. GSK-3α aggravates inflammation, metabolic derangement, and cardiac injury post-ischemia/reperfusion

    Abstract

    Reperfusion after acute myocardial infarction further exaggerates cardiac injury and adverse remodeling. Irrespective of cardiac cell types,...

    Firdos Ahmad, Hezlin Marzook, ... Rizwan Qaisar in Journal of Molecular Medicine
    Article 14 September 2023
  11. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways

    Background

    Pirfenidone (PFD) is effective for pulmonary fibrosis (PF), but its action mechanism has not been fully explained. This study explored the...

    Qun Lv, Jianjun Wang, ... Yifan Dai in Molecular Medicine
    Article Open access 24 May 2020
  12. GSK-126 Attenuates Cell Apoptosis in Ischemic Brain Injury by Modulating the EZH2-H3K27me3-Bcl2l1 Axis

    Whether epigenetic modifications participate in the cell apoptosis after ischemic stroke remains unclear. Histone 3 tri-methylation at lysine 27...

    Tai Zhou, Lei Zhang, ... Zhongcheng Wang in Molecular Neurobiology
    Article 22 November 2023
  13. Glycogen Synthase Kinase-3 Inhibitors Block Morphine-Induced Locomotor Activation, Straub Tail, and Depression of Rearing in Mice Via a Possible Central Action

    We investigated morphine-induced Straub’s tail reaction (STR) in mice pretreated with or without glycogen synthase kinase-3 (GSK-3) inhibitors...

    Junichi Kitanaka, Nobue Kitanaka, ... Tomoaki Sato in Neurochemical Research
    Article 13 March 2023
  14. Mechanistic Implications of GSK and CREB Crosstalk in Ischemia Injury

    Ischemia-reperfusion (IR) injury is a damage to an organ when the blood supply is less than the demand required for normal functioning, leading to...

    Heena Khan, Annu Bangar, ... Thakur Gurjeet Singh in Neurotoxicity Research
    Article 13 December 2023
  15. Corydaline alleviates Parkinson’s disease by regulating autophagy and GSK-3β phosphorylation

    Background

    Jitai tablet, a traditional Chinese medicine, has a neuroprotective effect on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine...

    Kaikai Zhou, Shasha Xu in Psychopharmacology
    Article 30 January 2024
  16. Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition

    Myocardial hypertrophy is a pathological thickening of the myocardium which ultimately results in heart failure. We previously reported that...

    Qian Wu, Wan-jie Liu, ... **-yong Yu in Acta Pharmacologica Sinica
    Article 14 December 2023
  17. Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer

    Background

    About 30% of Prostate cancer (PCa) patients progress to metastatic PCa that remains largely incurable. This evidence underlines the need...

    Valeria Pecci, Fabiola Troisi, ... Simona Nanni in Cancer Cell International
    Article Open access 05 February 2024
  18. Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway

    Background

    Diabetic encephalopathy is manifested by cognitive dysfunction. Salidroside, a nature compound isolated from Rhodiola rosea L , has the...

    Xue-Hua Wang, Zhong-Fu Zuo, ... De-Yu Zheng in Psychopharmacology
    Article 25 July 2023
  19. Osthole increases the radiosensitivity of hepatoma cells by inhibiting GSK-3β/AMPK/mTOR pathway-controlled glycolysis

    Osthole is a natural coumarin substance that has an inhibitory effect on hepatic cancer, but its radiosensitization effect on hepatoma cells has not...

    Hui Huang, Jie Xue, ... Mei-Lin **e in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 29 November 2022
  20. Pharmacological Modulation of the Cytosolic Oscillator Affects Glioblastoma Cell Biology

    The circadian system is a conserved time-kee** machinery that regulates a wide range of processes such as sleep/wake, feeding/fasting, and...

    Paula M. Wagner, Santiago J. Fornasier, Mario E. Guido in Cellular and Molecular Neurobiology
    Article Open access 22 June 2024
Did you find what you were looking for? Share feedback.